XML 70 R61.htm IDEA: XBRL DOCUMENT v3.23.3
Stockholders’ Equity (Deficit) - Schedule of Stock Options Roll Forward (Details) - USD ($)
$ / shares in Units, $ in Millions
9 Months Ended 12 Months Ended
Sep. 21, 2023
Sep. 30, 2023
Dec. 31, 2022
Shares Available for Future Grant      
Shares available for grant, beginning of period (in shares)   3,628,000  
Additional shares reserved (in shares)   24,800,000  
Options cancelled and forfeited (in shares)   4,000  
Shares withheld related to net share settlement (in shares)   20,671,000  
Restricted stock cancelled (in shares) 20,810,882    
Shares available for grant, ending of period (in shares)   42,230,000 3,628,000
Number of Options      
Options outstanding, beginning of period (in shares)   30,033,000  
Options exercised (in shares)   (10,033,000)  
Options cancelled and forfeited (in shares)   (4,000)  
Options outstanding, ending of period (in shares)   19,996,000 30,033,000
Options vested and expected to vest, exercisable (in shares)   19,996,000  
Options exercisable (in shares)   19,846,000  
Weighted-Average Exercise Price      
Options outstanding, weighted average exercise price (in dollars per share)   $ 8.57 $ 7.65
Options exercised, weighted average exercise price (in dollars per share)   5.81  
Options cancelled and forfeited, weighted average exercise price (in dollars per share)   3.79  
Options vested and expected to vest, exercisable, weighted average exercise price (in dollars per share)   8.57  
Options exercisable, weighted average exercise price (in dollars per share)   $ 8.28  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]      
Options, outstanding, weighted average remaining contractual term   3 years 7 months 9 days 4 years 1 month 28 days
Options vested and expected to vest, exercisable, weighted average remaining contractual term   3 years 7 months 9 days  
Options exercisable, weighted average remaining contractual term   3 years 6 months 29 days  
Options, outstanding, intrinsic value   $ 430 $ 685
Options vested and expected to vest, exercisable, aggregate intrinsic value   430  
Options exercisable, intrinsic value   $ 430  
Restricted stock units      
Shares Available for Future Grant      
Restricted stock units granted (in shares)   (10,127,000)  
Restricted stock units forfeited (in shares)   3,091,000  
Restricted stock cancelled (in shares)   15,630,394  
Restricted Stock      
Shares Available for Future Grant      
Restricted stock units granted (in shares)   0  
Restricted stock cancelled (in shares)   162,886